tiprankstipranks
Trending News
More News >
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Hong Kong Market

Giant Biogene Holding Co. Ltd. (2367) Financial Statements

Compare
2 Followers

Giant Biogene Holding Co. Ltd. Financial Overview

Giant Biogene Holding Co. Ltd.'s market cap is currently HK$86.03B. The company's EPS TTM is HK$1.128338274; its P/E ratio is 35.72; and it has a dividend yield of 0.59%. Giant Biogene Holding Co. Ltd. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$1.35. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 5.54B¥ 3.52B¥ 2.36B¥ 1.55B¥ 1.19B
Gross Profit¥ 4.55B¥ 2.95B¥ 2.00B¥ 1.35B¥ 1.01B
Operating Income¥ 2.31B¥ 1.66B¥ 1.19B¥ 914.57M¥ 651.81M
EBITDA¥ 2.31B¥ 1.78B¥ 1.21B¥ 938.78M¥ 674.10M
Net Income¥ 2.06B¥ 1.45B¥ 1.00B¥ 828.13M¥ 826.45M
Balance Sheet
Cash & Short-Term Investments¥ 5.86B¥ 3.78B¥ 2.20B¥ 7.26B¥ 1.96B
Total Assets¥ 8.04B¥ 4.97B¥ 3.14B¥ 7.88B¥ 2.65B
Total Debt¥ 6.71M¥ 2.73M¥ 2.59M¥ 0.00¥ 0.00
Net Debt¥ -4.02B¥ -2.50B¥ -1.33B¥ -7.10B¥ -367.81M
Total Liabilities¥ 918.14M¥ 602.03M¥ 301.19M¥ 6.86B¥ 2.19B
Stockholders' Equity¥ 7.11B¥ 4.36B¥ 2.83B¥ 1.02B¥ 458.00M
Cash Flow
Free Cash Flow¥ 0.00¥ 1.42B¥ 778.39M¥ 581.21M¥ 757.79M
Operating Cash Flow¥ 0.00¥ 1.65B¥ 931.64M¥ 692.40M¥ 834.12M
Investing Cash Flow¥ 0.00¥ -527.28M¥ -858.74M¥ 1.56B¥ -521.12M
Financing Cash Flow¥ 0.00¥ 51.81M¥ -5.79B¥ 4.48B¥ -17.52M
Currency in CNY

Giant Biogene Holding Co. Ltd. Earnings and Revenue History

Giant Biogene Holding Co. Ltd. Debt to Assets

Giant Biogene Holding Co. Ltd. Cash Flow

Giant Biogene Holding Co. Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis